We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
53 hedge funds and large institutions have $63.2M invested in CASI Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
74% more capital invested
Capital invested by funds: $36.4M → $63.2M (+$26.8M)
43% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 14
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
4% more funds holding
Funds holding: 51 → 53 (+2)
0.98% more ownership
Funds ownership: 1.14% → 2.12% (+0.98%)
Holders
53
Holders Change
+2
Holders Change %
+3.92%
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
8
Increased
20
Reduced
14
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WSC
Wellington Shields & Co
New York
|
+$4.14M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$268K |
| 3 |
State Street
Boston,
Massachusetts
|
+$247K |
| 4 |
Morgan Stanley
New York
|
+$175K |
| 5 |
BlackRock
New York
|
+$163K |
